Tropival

Tropival is a French biotechnology company dedicated to the development and production of vaccines for tropical diseases, with a primary focus on yellow fever. Founded in 2021 by industry veterans from Sanofi Pasteur, the company aims to address global supply shortages of the yellow fever vaccine using modern cell-culture manufacturing technologies. Their lead program is a live-attenuated yellow fever vaccine designed to provide a scalable and reliable alternative to traditional egg-based production methods. Based in the Lyon biocluster, Tropival leverages local expertise in vaccinology to advance its pipeline toward clinical evaluation. The company's mission is to ensure a stable supply of essential vaccines for regions most affected by tropical infectious diseases.